Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...
Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a ...
Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based ...
DelveInsight's Oncology-Based In-Vivo CRO Market Insights report provides the current and forecast market analysis, individual leading oncology-based in-vivo CRO companies' market shares, challenges, ...
Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Mid Cap Fund”.
The magnitude of the COVID-19 pandemic has tested the limits of the response capacities of governments, public health and healthcare infrastructure, and diagnostic laboratories. Over the first year of ...
Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Mid Cap Fund”.